APO Research
Talk to an analyst

APO RESEARCH · REPORT

Specialty Drug Distribution

Specialty distributor handle distribution to smaller specialty pharmacies and retail pharmacies.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Specialty distributor handle distribution to smaller specialty pharmacies and retail pharmacies.

It is common for each specialty pharmaceutical product to have its own go-to-market strategy. Because of the unique specialty drug product specifications, therapy regimens, drug product handling, storage and transportation requirements, pricing, reimbursement and other factors, drug distribution channels and methodologies are impacted and must be considered prior to product launch. Specialty drugs do not necessarily flow directly downstream to the patient via the dispensing pharmacist. Pharmacy benefit-controlled specialty drugs can be more tightly controlled in real time, improving the payers’ ability to track utilization.

Specialty drugs are produced by specialty pharmaceutical manufacturers then sent to specialty distributors or large specialty pharmacies. From there, they may be distributed directly to patients or be sent to retail pharmacies. Specialty drugs play an increasingly important role in the treatment of chronic conditions such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), etc.

Selected research

Market Outlook & Growth Opportunities

Global Specialty Drug Distribution Market Outlook and Growth Opportunities 2026

21 December 2025191 pages

Choose your research edition.

Industry ResearchSpecialty Drug Distribution Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Specialty Drug Distribution Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Specialty Drug Distribution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Specialty Drug Distribution Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Specialty Drug Distribution Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Specialty distributor handle distribution to smaller specialty pharmacies and retail pharmacies.

It is common for each specialty pharmaceutical product to have its own go-to-market strategy. Because of the unique specialty drug product specifications, therapy regimens, drug product handling, storage and transportation requirements, pricing, reimbursement and other factors, drug distribution channels and methodologies are impacted and must be considered prior to product launch. Specialty drugs do not necessarily flow directly downstream to the patient via the dispensing pharmacist. Pharmacy benefit-controlled specialty drugs can be more tightly controlled in real time, improving the payers’ ability to track utilization.

Specialty drugs are produced by specialty pharmaceutical manufacturers then sent to specialty distributors or large specialty pharmacies. From there, they may be distributed directly to patients or be sent to retail pharmacies. Specialty drugs play an increasingly important role in the treatment of chronic conditions such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), etc.

Read the full market overview

Global Specialty Drug Distribution key players include Amerisource, Mckesson, Cardinal Health, PHOENIX group, etc.

North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.

In terms of product, Oncology is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospital and Clinics, followed by Pharmacy, etc.

This report provides an overview of the global Specialty Drug Distribution market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Specialty Drug Distribution and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Specialty Drug Distribution revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Specialty Drug Distribution market.

Specialty Drug Distribution Segment by Company

AmerisourceBergen

Mckesson

Cardinal Health

Phoenix

Medipal Holdings

Alliance Healthcare

Sinopharm

Express Scripts

Shanghai Pharma

Anda

Jointown

Max Pharma

Specialty Drug Distribution Segment by Type

Oncology

Rheumatoid Arthritis

Multiple Sclerosis

Hemophilia

Others

Specialty Drug Distribution Segment by Application

Hospital and Clinic

Pharmacy

Others

Specialty Drug Distribution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Specialty Drug Distribution status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Specialty Drug Distribution key companies, revenue, market share, and recent developments.

3. To split the Specialty Drug Distribution breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Specialty Drug Distribution market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Specialty Drug Distribution significant trends, drivers, influence factors in global and regions.

6. To analyze Specialty Drug Distribution competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Specialty Drug Distribution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Specialty Drug Distribution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Specialty Drug Distribution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Specialty Drug Distribution industry.

Chapter 3: Detailed analysis of Specialty Drug Distribution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Specialty Drug Distribution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Specialty Drug Distribution in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Specialty Drug Distribution Industry Trends Table 2. Specialty Drug Distribution Industry Drivers Table 3. Specialty Drug Distribution Industry Opportunities and Challenges Table 4. Specialty Drug Distribution Industry Restraints Table 5. Global Specialty Drug Distribution Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Specialty Drug Distribution Revenue Share by Company (2021-2026) Table 7. Global Specialty Drug Distribution Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Specialty Drug Distribution Key Company Manufacturing Base & Headquarters Table 9. Global Specialty Drug Distribution Company, Product Type & Application Table 10. Global Specialty Drug Distribution Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Specialty Drug Distribution by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Oncology Table 15. Significant Companies of Rheumatoid Arthritis Table 16. Significant Companies of Multiple Sclerosis Table 17. Significant Companies of Hemophilia Table 18. Significant Companies of Others Table 19. Global Specialty Drug Distribution Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Specialty Drug Distribution Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Specialty Drug Distribution Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Specialty Drug Distribution Sales Value Share by Type (2021-2026) Table 23. Global Specialty Drug Distribution Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Hospital and Clinic Table 25. Significant Companies of Pharmacy Table 26. Significant Companies of Others Table 27. Global Specialty Drug Distribution Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Specialty Drug Distribution Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Specialty Drug Distribution Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Specialty Drug Distribution Sales Value Share by Application (2021-2026) Table 31. Global Specialty Drug Distribution Sales Value Share by Application (2027-2032) Table 32. Global Specialty Drug Distribution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Specialty Drug Distribution Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Specialty Drug Distribution Sales Value Share by Region (2021-2026) Table 35. Global Specialty Drug Distribution Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Specialty Drug Distribution Sales Value Share by Region (2027-2032) Table 37. Global Specialty Drug Distribution Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Specialty Drug Distribution Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Specialty Drug Distribution Sales Value Market Share by Country (2021-2026) Table 40. Global Specialty Drug Distribution Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Specialty Drug Distribution Sales Value Market Share by Country (2027-2032) Table 42. AmerisourceBergen Company Information Table 43. AmerisourceBergen Business Overview Table 44. AmerisourceBergen Specialty Drug Distribution Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. AmerisourceBergen Specialty Drug Distribution Product Portfolio Table 46. AmerisourceBergen Recent Development Table 47. Mckesson Company Information Table 48. Mckesson Business Overview Table 49. Mckesson Specialty Drug Distribution Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Mckesson Specialty Drug Distribution Product Portfolio Table 51. Mckesson Recent Development Table 52. Cardinal Health Company Information Table 53. Cardinal Health Business Overview Table 54. Cardinal Health Specialty Drug Distribution Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Cardinal Health Specialty Drug Distribution Product Portfolio Table 56. Cardinal Health Recent Development Table 57. Phoenix Company Information Table 58. Phoenix Business Overview Table 59. Phoenix Specialty Drug Distribution Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Phoenix Specialty Drug Distribution Product Portfolio Table 61. Phoenix Recent Development Table 62. Medipal Holdings Company Information Table 63. Medipal Holdings Business Overview Table 64. Medipal Holdings Specialty Drug Distribution Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Medipal Holdings Specialty Drug Distribution Product Portfolio Table 66. Medipal Holdings Recent Development Table 67. Alliance Healthcare Company Information Table 68. Alliance Healthcare Business Overview Table 69. Alliance Healthcare Specialty Drug Distribution Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Alliance Healthcare Specialty Drug Distribution Product Portfolio Table 71. Alliance Healthcare Recent Development Table 72. Sinopharm Company Information Table 73. Sinopharm Business Overview Table 74. Sinopharm Specialty Drug Distribution Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Sinopharm Specialty Drug Distribution Product Portfolio Table 76. Sinopharm Recent Development Table 77. Express Scripts Company Information Table 78. Express Scripts Business Overview Table 79. Express Scripts Specialty Drug Distribution Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Express Scripts Specialty Drug Distribution Product Portfolio Table 81. Express Scripts Recent Development Table 82. Shanghai Pharma Company Information Table 83. Shanghai Pharma Business Overview Table 84. Shanghai Pharma Specialty Drug Distribution Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Shanghai Pharma Specialty Drug Distribution Product Portfolio Table 86. Shanghai Pharma Recent Development Table 87. Anda Company Information Table 88. Anda Business Overview Table 89. Anda Specialty Drug Distribution Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Anda Specialty Drug Distribution Product Portfolio Table 91. Anda Recent Development Table 92. Jointown Company Information Table 93. Jointown Business Overview Table 94. Jointown Specialty Drug Distribution Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 95. Jointown Specialty Drug Distribution Product Portfolio Table 96. Jointown Recent Development Table 97. Max Pharma Company Information Table 98. Max Pharma Business Overview Table 99. Max Pharma Specialty Drug Distribution Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 100. Max Pharma Specialty Drug Distribution Product Portfolio Table 101. Max Pharma Recent Development Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Specialty Drug Distribution Product Image Figure 2. Global Specialty Drug Distribution Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Specialty Drug Distribution Market Size (2021-2032) & (US$ Million) Figure 4. Global Specialty Drug Distribution Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Oncology Image Figure 8. Rheumatoid Arthritis Image Figure 9. Multiple Sclerosis Image Figure 10. Hemophilia Image Figure 11. Others Image Figure 12. Global Specialty Drug Distribution Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Specialty Drug Distribution Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Specialty Drug Distribution Sales Value Share by Type (2021-2032) Figure 15. Hospital and Clinic Image Figure 16. Pharmacy Image Figure 17. Others Image Figure 18. Global Specialty Drug Distribution Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Specialty Drug Distribution Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Specialty Drug Distribution Sales Value Share by Application (2021-2032) Figure 21. Global Specialty Drug Distribution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Specialty Drug Distribution Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Specialty Drug Distribution Sales Value (2021-2032) & (US$ Million) Figure 24. North America Specialty Drug Distribution Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Specialty Drug Distribution Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Specialty Drug Distribution Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Specialty Drug Distribution Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Specialty Drug Distribution Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Specialty Drug Distribution Sales Value (2021-2032) & (US$ Million) Figure 30. South America Specialty Drug Distribution Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Specialty Drug Distribution Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Specialty Drug Distribution Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Specialty Drug Distribution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Oncology
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Hemophilia
  • Others
Applications
  • Hospital and Clinic
  • Pharmacy
  • Others
Companies covered
  • AmerisourceBergen
  • Mckesson
  • Cardinal Health
  • Phoenix
  • Medipal Holdings
  • Alliance Healthcare
  • Sinopharm
  • Express Scripts
  • Shanghai Pharma
  • Anda
  • Jointown
  • Max Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Specialty Drug Distribution Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Specialty Drug Distribution Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Specialty Drug Distribution Market Dynamics
  1. 2.1 Specialty Drug Distribution Industry Trends
  2. 2.2 Specialty Drug Distribution Industry Drivers
  3. 2.3 Specialty Drug Distribution Industry Opportunities and Challenges
  4. 2.4 Specialty Drug Distribution Industry Restraints
3 Specialty Drug Distribution Market by Company
  1. 3.1 Global Specialty Drug Distribution Company Revenue Ranking in 2025
  2. 3.2 Global Specialty Drug Distribution Revenue by Company (2021-2026)
  3. 3.3 Global Specialty Drug Distribution Company Ranking (2024-2026)
  4. 3.4 Global Specialty Drug Distribution Company Manufacturing Base and Headquarters
  5. 3.5 Global Specialty Drug Distribution Company Product Type and Application
  6. 3.6 Global Specialty Drug Distribution Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Specialty Drug Distribution Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Specialty Drug Distribution Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Specialty Drug Distribution Market by Type
  1. 4.1 Specialty Drug Distribution Type Introduction
  2. 4.1.1 Oncology
  3. 4.1.2 Rheumatoid Arthritis
  4. 4.1.3 Multiple Sclerosis
  5. 4.1.4 Hemophilia
  6. 4.1.5 Others
  7. 4.2 Global Specialty Drug Distribution Sales Value by Type
  8. 4.2.1 Global Specialty Drug Distribution Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Specialty Drug Distribution Sales Value by Type (2021-2032)
  10. 4.2.3 Global Specialty Drug Distribution Sales Value Share by Type (2021-2032)
5 Specialty Drug Distribution Market by Application
  1. 5.1 Specialty Drug Distribution Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Others
  5. 5.2 Global Specialty Drug Distribution Sales Value by Application
  6. 5.2.1 Global Specialty Drug Distribution Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Specialty Drug Distribution Sales Value by Application (2021-2032)
  8. 5.2.3 Global Specialty Drug Distribution Sales Value Share by Application (2021-2032)
6 Specialty Drug Distribution Regional Value Analysis
  1. 6.1 Global Specialty Drug Distribution Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Specialty Drug Distribution Sales Value by Region (2021-2032)
  3. 6.2.1 Global Specialty Drug Distribution Sales Value by Region: 2021-2026
  4. 6.2.2 Global Specialty Drug Distribution Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Specialty Drug Distribution Sales Value (2021-2032)
  7. 6.3.2 North America Specialty Drug Distribution Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Specialty Drug Distribution Sales Value (2021-2032)
  10. 6.4.2 Europe Specialty Drug Distribution Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Specialty Drug Distribution Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Specialty Drug Distribution Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Specialty Drug Distribution Sales Value (2021-2032)
  16. 6.6.2 South America Specialty Drug Distribution Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Specialty Drug Distribution Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Specialty Drug Distribution Sales Value Share by Country, 2025 VS 2032
7 Specialty Drug Distribution Country-level Value Analysis
  1. 7.1 Global Specialty Drug Distribution Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Specialty Drug Distribution Sales Value by Country (2021-2032)
  3. 7.2.1 Global Specialty Drug Distribution Sales Value by Country (2021-2026)
  4. 7.2.2 Global Specialty Drug Distribution Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Specialty Drug Distribution Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Specialty Drug Distribution Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Specialty Drug Distribution Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AmerisourceBergen
  2. 8.1.1 AmerisourceBergen Company Information
  3. 8.1.2 AmerisourceBergen Business Overview
  4. 8.1.3 AmerisourceBergen Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AmerisourceBergen Specialty Drug Distribution Product Portfolio
  6. 8.1.5 AmerisourceBergen Recent Developments
  7. 8.2 Mckesson
  8. 8.2.1 Mckesson Company Information
  9. 8.2.2 Mckesson Business Overview
  10. 8.2.3 Mckesson Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mckesson Specialty Drug Distribution Product Portfolio
  12. 8.2.5 Mckesson Recent Developments
  13. 8.3 Cardinal Health
  14. 8.3.1 Cardinal Health Company Information
  15. 8.3.2 Cardinal Health Business Overview
  16. 8.3.3 Cardinal Health Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cardinal Health Specialty Drug Distribution Product Portfolio
  18. 8.3.5 Cardinal Health Recent Developments
  19. 8.4 Phoenix
  20. 8.4.1 Phoenix Company Information
  21. 8.4.2 Phoenix Business Overview
  22. 8.4.3 Phoenix Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Phoenix Specialty Drug Distribution Product Portfolio
  24. 8.4.5 Phoenix Recent Developments
  25. 8.5 Medipal Holdings
  26. 8.5.1 Medipal Holdings Company Information
  27. 8.5.2 Medipal Holdings Business Overview
  28. 8.5.3 Medipal Holdings Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Medipal Holdings Specialty Drug Distribution Product Portfolio
  30. 8.5.5 Medipal Holdings Recent Developments
  31. 8.6 Alliance Healthcare
  32. 8.6.1 Alliance Healthcare Company Information
  33. 8.6.2 Alliance Healthcare Business Overview
  34. 8.6.3 Alliance Healthcare Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Alliance Healthcare Specialty Drug Distribution Product Portfolio
  36. 8.6.5 Alliance Healthcare Recent Developments
  37. 8.7 Sinopharm
  38. 8.7.1 Sinopharm Company Information
  39. 8.7.2 Sinopharm Business Overview
  40. 8.7.3 Sinopharm Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sinopharm Specialty Drug Distribution Product Portfolio
  42. 8.7.5 Sinopharm Recent Developments
  43. 8.8 Express Scripts
  44. 8.8.1 Express Scripts Company Information
  45. 8.8.2 Express Scripts Business Overview
  46. 8.8.3 Express Scripts Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Express Scripts Specialty Drug Distribution Product Portfolio
  48. 8.8.5 Express Scripts Recent Developments
  49. 8.9 Shanghai Pharma
  50. 8.9.1 Shanghai Pharma Company Information
  51. 8.9.2 Shanghai Pharma Business Overview
  52. 8.9.3 Shanghai Pharma Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Shanghai Pharma Specialty Drug Distribution Product Portfolio
  54. 8.9.5 Shanghai Pharma Recent Developments
  55. 8.10 Anda
  56. 8.10.1 Anda Company Information
  57. 8.10.2 Anda Business Overview
  58. 8.10.3 Anda Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Anda Specialty Drug Distribution Product Portfolio
  60. 8.10.5 Anda Recent Developments
  61. 8.11 Jointown
  62. 8.11.1 Jointown Company Information
  63. 8.11.2 Jointown Business Overview
  64. 8.11.3 Jointown Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Jointown Specialty Drug Distribution Product Portfolio
  66. 8.11.5 Jointown Recent Developments
  67. 8.12 Max Pharma
  68. 8.12.1 Max Pharma Company Information
  69. 8.12.2 Max Pharma Business Overview
  70. 8.12.3 Max Pharma Specialty Drug Distribution Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Max Pharma Specialty Drug Distribution Product Portfolio
  72. 8.12.5 Max Pharma Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst